Overall volumes in futures & options currently stand at 1.80 crore contracts with a turnover of Rs. 18,20,233.69 crore.

Overall volumes in futures & options currently stand at 1.80 crore contracts with a turnover of Rs. 18,20,233.69 crore.

Retail investors have increased their presence in mutual fund investment. Read on to find where are they investing and who is helping them.

The company has received Rs. 975 crore micro irrigation order for the Mohanpura Major Project in the state of Madhya Pradesh, said a press release on Friday.

Indian stock markets are seen opening on a flat note tracking dull cues from Asian markets. The trading of Nifty 50 index future on the Singapore stock exchanges indicates that Nifty could rise 2 points at the opening bell. It would be a busy day on the earnings front with companies such as Atul, Bajaj Auto, Bata India, Ceat, Havells India, HDFC Standard Life Insurance, Kansai Nerolac Paints, L&T Finance Holding, MCX and Wipro will announce their earnings today. Apart from earnings, market participants will keep an eye on the big event of no-confidence motion tabled by opposition parties against the Modi’s government will be debated in Lok Sabha today.  

The zone of 10,900-10,930 remains crucial support and as long as bulls manage to defend this support, the inherent undercurrent will continue to stay bullish. Upon decisive breach of 10,900-10,930 level, the level of 10,870 would act as a support. Stocks in news: Maruti Suzuki India, Parag Milk Foods, Alembic Pharmaceuticals, Fortis Healthcare, Reliance Communications, Hatsun Agro Products, JSW Steel and Andhra Bank. 

The stock that are most likely to witness a significant movement on the bourses on July 20 are, Infosys, DCM Shriram, Kotak Mahindra and Bajaj Finserv.

Bajaj Finance reported strong results for the quarter ended Q1FY19 with strong growth of 35 per cent YoY in advances

The new axle load norms initiated by the government has proven to be a hazard to the commercial vehicle demand. The industry is jolted by the sudden change in the norms and its wide-ranging effects on the industry, going forward.

Leading pharma company Lupin Limited received tentative FDA approval for generic Tadalafil Tablets of USP, 2.5 mg, 5 mg, 10 mg, and 20 mg.